We recently published a list of Jim Cramer’s Latest Lightning Round: 7 Stocks in Focus. In this article, we are going to take ...

Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

and the competing kits sold by Fluent, are designed to run on machines made by Illumina. In its deal announcement late Tuesday, Illumina said its sequencing platform would remain “open,” and ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

Next-generation sequencing (NGS) technology, which has been used at Illumina since 2007, builds upon earlier genome sequencing methods to greatly reduce the time taken to sequence DNA. When the ...

being held in Florida—where the DNA sequencing giant is set to unveil more details and demonstrations—and follows up on Illumina’s recent expansions into proteomics and single-cell analysis.

Illumina and next-gen sequencing (NGS) are synonymous ... The product will be a kit, which will be distributed with substrates (slides), reagents, and a consumable holder. Users will go through ...

Illumina aims to transform human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related consumables to ...